Neuroene Therapeutics will be at the NHLBI Innovation Conference and Life Sciences Summit, New York City, November 5 and 7, 2019
Neuroene selected by CED to present on the main stage at the CED Life Science Conference in Raleigh this February 26-27
EurekAlert: Neuroene Therapeutics awarded $1.5 million to develop anti-seizure compound for epilepsy
Selection of Neuroene Therapeutics as an Early-Stage presenting company at the SEBIO Investor Forum in Atlanta
For the "Entrepreneurship: turning your innovative ideas into a marketable product" workshop.
Compositions and methods for treating neurological diseases or injury. Issued on January 9, 2018